Philips Collaborates with Accenture to Create First Proof of Concept for Delivering Vital Patient Data via Google Glass

Royal Philips ElectronicsRoyal Philips (NYSE: PHG AEX: PHIA) and Accenture (NYSE: CAN) announced the creation of a proof-of-concept demonstration that uses a Google Glass™ head-mounted display for researching ways to improve the effectiveness and efficiency of performing surgical procedures. The demonstration connects Google Glass to Philips IntelliVue Solutions and proves the concept of seamless transfer of patient vital signs into Google Glass, potentially providing clinicians with hands-free access to critical clinical information.

The new concept demonstration depicts how a clinician wearing the display could simultaneously monitor a patient's vital signs and react to surgical procedural developments without having to turn away from the patient or procedure. A clinician could also monitor a patient's vital signs remotely or enlist assistance from clinicians in other locations.

"We live in a world where being nimble is key and industry-altering ideas need to be converted to practical solutions that people can use," said Michael Mancuso, CEO, Patient Care and Clinical Informatics at Philips Healthcare. "This research explores how clinicians can achieve better access to the right information at the right time so they can focus on more efficient and effective patient care. It's a first step in researching how existing technologies can be applied to improve the quality of life of patients."

Researchers from Philips' newly created 'Digital Accelerator Lab,' a cross-sector innovation platform with labs based in the Netherlands and India, collaborated with researchers from Accenture Technology Labs to explore the potential use of Google Glass in clinical settings. The goal was to create the first proof of concept for Google Glass and Philips IntelliVue Solutions and then to begin exploring additional opportunities to integrate Google Glass seamlessly with Philips' healthcare solutions.

"Accenture's work with Philips showcases a powerful use of wearable devices in the healthcare industry, helping physicians perform their jobs more effectively and enhancing care for patients," said Paul Daugherty, chief technology officer, Accenture. "This exciting work highlights the potential of digital technologies to transform the way we work and live, and we're pleased to have collaborated with Philips to help bring this vision to life."

Aside from the possibility of operating in a hands-free environment, the Google Glass IntelliVue Solution research effort was developed to explore how to enhance a clinician's mobility by allowing the seamless transfer of patient information while on the go. Further research may indicate how to possibly enable clinicians and anesthesiologists to keep their focus on the patient while simultaneously obtaining a live view of critical patient monitoring data.

Additional topics for research may include:

  • Accessing a near real-time feed of vital signs in Google Glass;
  • Calling up images and other patient data by clinicians from anywhere in the hospital;
  • Accessing a pre-surgery safety checklist;
  • Giving clinicians the ability to view the patient in the recovery room after surgery;
  • Conducting live, first-person point-of-view videoconferences with other clinicians or medical personnel; and
  • Recording surgeries from a first-person point-of-view for training purposes.

The Philips Digital Accelerator Lab underlines Philips' commitment to developing innovative solutions across the care continuum, to improve patient outcomes, provide better value and expand access to care. Today, Philips offers a comprehensive portfolio of patient monitoring solutions ranging from bedside monitors to wearable patient monitors, combined with clinical decision support tools and mobile applications to provide immediate access to centrally held patient data. More than 190 million patients are monitored each year with Philips' patient monitors.

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

About Accenture
Accenture is a global management consulting, technology services and outsourcing company, with approximately 275,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world's most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...